All Active Grants

783 grants
75d left D

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

National Institutes of Health May 07, 2026
$1,500,000

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA

75d left D

Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
Not specified

The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously

75d left D

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AID

75d left D

Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AID

75d left D

NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
$200,000

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this Nationa

75d left D

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

This Notice of Funding Opportunity (NOFO) invites research grant applications that propose the development and evaluation of novel radioligands for po

75d left D

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
Not specified

The objective of this Notice of Funding Opportunity (NOFO) is to stimulate research in 1) discovery and development of novel, small molecules for thei

75d left D

Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
$75,000

The Office of Research Infrastructure Programs (ORIP) within the Division of Program Coordination, Planning, and Strategic Initiatives announces an op

75d left D

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregna

75d left D

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregna

75d left D

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
Not specified

The purpose of this NOFO is to announce support for meritorious research projects that address research questions relevant to human dental, oral, or c

75d left D

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
Not specified

The purpose of this NOFO is to announce support for meritorious research projects that address research questions relevant to human dental, oral, or c

75d left D

Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)

National Institutes of Health May 07, 2026
Not specified

This Notice of Funding Funding Opportunity (NOFO) supports research on expectancy-generating factors and measures of their effects on expectancies and

75d left D

HIV Prevention and Alcohol (R01 Clinical Trials Optional)

National Institutes of Health May 07, 2026
Not specified

The NOFO seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and

75d left D

HIV Prevention and Alcohol (R34 Clinical Trials Optional)

National Institutes of Health May 07, 2026
$450,000

The NOFO seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and

75d left D

Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
Not specified

The purpose of this notice of funding opportunity (NOFO) is to support the investigation of HIV-1 Envelope (Env) cell surface expression, the structur

75d left D

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
Not specified

This purpose of this NOFO is to support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker valida

75d left D

Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
$500,000

The purpose of this notice of funding opportunity (NOFO) is to support research to define the impact of defective HIV proviruses on mechanisms of HIV

75d left D

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

National Institutes of Health May 07, 2026
$400,000

The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early

75d left D

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
$225,000

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strateg

75d left D

Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Insti

75d left D

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive

75d left D

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

National Institutes of Health May 07, 2026
Not specified

The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institu

75d left D

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

National Institutes of Health May 07, 2026
Not specified

This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of th

75d left D

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

National Institutes of Health May 07, 2026
Not specified

This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scienti